International call for research proposals on rare cancer drug development (ATTRACT)Funder(s): Anticancer Fund, Dutch Cancer Society, Kom op tegen Kanker, Asociación Española Contra el Cáncer, The Fondation ARC,
Five European anti-cancer charities are joining forces to stimulate international research on rare cancer drug development. The focus of this joint international call, the ATTRACT-Call, is on late phase (2/3) clinical trials on rare cancer drugs. Main goals are improving treatment for rare cancer patients and accelerate the development of drugs for rare cancers. We encourage researchers and clinicians from different countries to join forces, share knowledge, and collaborate.
Eligible for this call are multicenter, international phase 2/3 clinical trials on medicinal products for rare cancer treatment (including drug repurposing). Main applicants as well as research consortium partners should be located in one of the funding countries (Belgium, France, the Netherlands, Spain), with a minimum of 2 participating countries. Applicants (funding recipients) should be either Academic research groups or Clinical/Public health sector research groups. To support swift enrolment of study patients in clinical trials, inclusion centers outside of the funding countries may be included in the proposal. Public-private collaborations are accepted under strict conditions; note that private parties will not receive direct funding. Active patient participation in the set up and execution of the proposals is required. A strong regulatory and implementation strategy (incl. EMA advise, orphan designation, early HTA) is not obliged but highly recommended.
Requirements & Guidelines
All information regarding the ATTRACT-call, including background, scope, application requirements, preferences and recommendations, review procedure, timelines, funding conditions and estimated budgets can be found in the Guidelines for Applicants (available for download below). Please read them carefully.
The call will make use of a pre- and full proposal review process. Applications have to be submitted via the electronic application system of KWF: Grant Management System (GMS). Please note that registration in the system is required prior to submitting your application. It is recommended to register as soon as possible. Please check at least six weeks before the call deadline if your registration is approved. Instructions how to register are provided in the Instructions for GMS for Applicants (available for download below). A preview of the application form is also available for download, but please do not use it to submit. You have to apply via the form in GMS.
Timeline & Milestones
October 11, 2022
Deadline First stage (LOI / pre-proposal)
January 31, 2023
Announcement of Applicants selected for stage 2
April 6, 2023
Deadline Full Application
June 27, 2023
Grant Decision – Final Decision – Awarding
December 1, 2023